HMN 2025: How Stevia leaf extract has potential as anticancer therapy, researchers discover

Stevia could present extra advantages than as a zero-calorie sugar substitute. When fermented with micro organism remoted from banana leaves, stevia extract kills off pancreatic cancer cells however does not hurt wholesome kidney cells, based on a analysis crew at Hiroshima University.

The researchers revealed their findings on April 28 within the International Journal of Molecular Sciences.

“Globally, the incidence and mortality charges of pancreatic cancer proceed to rise, with a five-year survival price of lower than 10%,” mentioned co-author Narandalai Danshiitsoodol, affiliate professor in Department of Probiotic Science for Preventive Medicine, Graduate School of Biomedical and Health Sciences.

“Pancreatic cancer is extremely invasive and vulnerable to metastasis, displaying important resistance to present therapies, reminiscent of surgical procedure, radiotherapy and chemotherapy. As such, there’s an pressing must determine new and efficient anticancer compounds, significantly these derived from medicinal crops.”

Prior research by different researchers indicated that stevia leaf extract demonstrated potential as an anticancer drug, however isolating and making use of the precise bioactive parts that defend towards cancer cells has remained difficult, Danshiitsoodol mentioned. However, fermenting with micro organism can structurally change the extract and produce bioactive metabolites, that are compounds that may affect dwelling organisms.

“To improve the pharmacological efficacy of pure plant extracts, microbial biotransformation has emerged as an efficient technique,” mentioned corresponding writer Masanori Sugiyama, professor within the Department of Probiotic Science for Preventive Medicine, Graduate School of Biomedical and Health Sciences. Sugiyama’s lab has remoted and evaluated the well being advantages of greater than 1,300 lactic acid micro organism (LAB) strains from fruits, greens, flowers and medicinal crops.

“In this study, we aimed to check LAB-fermented and non-fermented extracts to determine key compounds that improve bioactivity, in the end contributing to the efficacy of natural drugs in cancer prevention and remedy.”

Specifically, the crew fermented stevia leaf extract with plant-derived Lactobacillus plantarum SN13T pressure (FSLE) and in contrast its results on pancreatic cancer (PANC-1) cells within the lab, alongside non-cancerous human embryonic kidney cells HEK-293, to the results of non-fermented stevia extract. The cells utilized in these experiments have been acquired from established business cell traces.

“Our findings point out that FSLE demonstrates considerably larger cytotoxicity than the non-fermented extract at equal concentrations, suggesting that the fermentation course of enhances the bioactivity of the extract,” Sugiyama mentioned. “Notably, FSLE exhibited decrease toxicity towards the HEK-293 cells, with minimal inhibition noticed even on the highest focus examined.”

Additional analyses recognized chlorogenic acid methyl ester (CAME) because the lively anti-cancer compound. When fermented, the focus of chlorogenic acid within the extract dropped six-fold, indicating a microbial transformation, based on Danshiitsoodol.

“This microbial transformation was doubtless attributable to particular enzymes within the micro organism pressure used,” Danshiitsoodol mentioned. “Our knowledge exhibit that CAME displays stronger toxicity to cells and pro-apoptotic results—which encourage cell dying—on PANC-1 cells in comparison with chlorogenic acid alone.”

Next, the researchers mentioned they plan to review the results in a mouse model to higher perceive the effectiveness of varied dosages throughout a whole-body system.

“The current study has considerably enhanced our understanding of the mechanism of motion of the Lactobacillus plantarum SN13T pressure within the fermentation of natural extracts, whereas additionally providing a useful analysis perspective on the potential utility of probiotics as pure anti-tumor brokers,” Danshiitsoodol mentioned.

Other contributors embrace Rentao Zhang and Masafumi Noda, Department of Probiotic Science for Preventive Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University; and Sayaka Yonezawa and Keishi Kanno, Department of General Internal Medicine, Hiroshima University Hospital.